Crossref journal-article
Elsevier BV
Antiviral Research (78)
Bibliography

Wyde, P. R., Chetty, S. N., Timmerman, P., Gilbert, B. E., & Andries, K. (2003). Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection. Antiviral Research, 60(3), 221–231.

Authors 5
  1. Philip R Wyde (first)
  2. Srikrishna N Chetty (additional)
  3. Philip Timmerman (additional)
  4. Brian E Gilbert (additional)
  5. Koen Andries (additional)
References 24 Referenced 43
  1. 10.1002/jmv.1890300208 / J. Med. Virol. / An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings by Agius (1990)
  2. Andries, K., Moeremans, M., Gevers, T., Willebrords, R., Lacrampe, J., Janssens, F., 2000. R170591, a novel fusion inhibitor with picomolar activity against respiratory syncytial virus (RSV). In: Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 17–20 September, 2000 (Abstracts).
  3. Andries, K., Moeremans, M., Gevers, T., Willebords, R., Sommen, C., Lacrampe, J., Janssens, F., Wyde, P.R., in press. Substituted benzimidazoles with nanoMolar activity against respiratory syncytial virus. Antivir. Res. (10.1016/j.antiviral.2003.07.004)
  4. 10.1002/ppul.1084 / Pediatr. Pulmonol. / Respiratory syncytial virus immune globulin: decisions and cost by Barton (2001)
  5. Committee on Infectious Diseases, 1993. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 92, 501–504. (10.1542/peds.92.3.501)
  6. 10.1016/S0002-9343(97)00003-X / Am. J. Med. / Respiratory viral infections in immunocompetent and immunocompromised persons by Couch (1997)
  7. 10.1093/infdis/172.2.389 / J. Infect. Dis. / Respiratory syncytial virus and influenza a infections in the hospitalized elderly by Falsey (1995)
  8. 10.1016/S0140-6736(05)80082-0 / Lancet / Respiratory syncytial virus or influenza by Fleming (1993)
  9. 10.1016/0166-3542(92)90088-M / Antivir. Res. / Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory synctytial virus infection in cotton rats by Gilbert (1992)
  10. Hall, C.B., McCarthy, C.A., 2000. Respiratory syncytial virus. In: Mandell, G.L., Bennett, J.E., Dolin, R. (Eds.), Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Churchill Livingston, Philadelphia, pp. 1782–1801.
  11. {'key': '10.1016/j.antiviral.2003.07.002_BIB11', 'first-page': '284', 'article-title': 'Prophylaxis in RSV infection (Palivizumab)—is it worthwhile?', 'volume': '93', 'author': 'Hashmi', 'year': '2000', 'journal-title': 'Ir. Med. J.'} / Ir. Med. J. / Prophylaxis in RSV infection (Palivizumab)—is it worthwhile? by Hashmi (2000)
  12. 10.1016/0165-1218(87)90111-X / Mutat. Res. / Dominant lethal study of ribavirin in male rats by Hoffmann (1987)
  13. 10.1016/S0378-4347(98)00136-4 / Rev. J. Chromatogr. / Chloroformates in gas chromatography as general purpose derivatizing agents by Husek (1998)
  14. 10.1007/BF01975037 / Eur. J. Clin. Microbiol. Infect. Dis. / Antiviral therapy with small particle aerosols by Knight (1988)
  15. 10.1097/00006454-200205000-00037 / Pediatr. Infect. Dis. J. / Safety issues related to the administration of ribavirin by Krilov (2002)
  16. 10.1016/S0149-2918(00)83032-5 / Clin. Ther. / Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis by Lofland (2000)
  17. 10.1016/S0022-3476(95)70434-5 / J. Pediatr. / Cost of ribavirin therapy for respiratory syncytial virus infection by Marquardt (1995)
  18. 10.1046/j.1440-1754.2000.00303.x / J. Paediatr. Child. Health / Outcome of respiratory syncytial virus infection and a cost-benefit analysis of prophylaxis by Numa (2000)
  19. Rhodes, A.J., Van Rooyen, C.E., 1953. Textbook of Virology, 2nd ed. Williams and Wilkins, Baltimore, MD, pp. 66–69. (10.4269/ajtmh.1953.2.5.TM0020050943a)
  20. 10.1542/peds.100.3.417 / Pediatrics / RSV-IGIV therapy: a cost/benefit analysis by Thakur (1997)
  21. 10.1001/jama.289.2.179 / JAMA / Mortality associated with influenza and respiratory syncytial virus in the United States by Thompson (2003)
  22. 10.1128/AAC.17.4.642 / Antimicrob. Agents Chemother. / Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice by Wilson (1980)
  23. 10.1016/0166-3542(87)90029-5 / Antivir. Res. / Efficacy of high dose-short duration ribavirin aerosol in the treatment of respiratory syncytial virus infected cotton rats and influenza B virus infected mice by Wyde (1987)
  24. 10.1203/00006450-199510000-00012 / Pediatr. Res. / Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats by Wyde (1995)
Dates
Type When
Created 21 years, 11 months ago (Sept. 16, 2003, 5:11 p.m.)
Deposited 8 months, 1 week ago (Dec. 13, 2024, 3:14 p.m.)
Indexed 3 months, 2 weeks ago (May 10, 2025, 12:28 a.m.)
Issued 21 years, 9 months ago (Nov. 1, 2003)
Published 21 years, 9 months ago (Nov. 1, 2003)
Published Print 21 years, 9 months ago (Nov. 1, 2003)
Funders 0

None

@article{Wyde_2003, title={Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection}, volume={60}, ISSN={0166-3542}, url={http://dx.doi.org/10.1016/j.antiviral.2003.07.002}, DOI={10.1016/j.antiviral.2003.07.002}, number={3}, journal={Antiviral Research}, publisher={Elsevier BV}, author={Wyde, Philip R and Chetty, Srikrishna N and Timmerman, Philip and Gilbert, Brian E and Andries, Koen}, year={2003}, month=nov, pages={221–231} }